These results, together with a prior report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the principle of concentrating on ACKR3 as a novel strategy to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders. January 3, 2024 Donating https://thomase803zwk6.answerblogs.com/profile